Top Ten Common Prejudices About Polyethylene Naphthalate Market.

-
Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...
1 comment

15 Easy Ways To Facilitate Stem Cell Banking Market.

-


The global stem cell banking market is expected to grow at an annual rate of 8.4% from USD 6,290.6 million in 2018 to USD 9,415.4 million in 2023. The growth of the stem cell banking market is being fueled by factors such as increased awareness of stem cells' therapeutic potential, the development of novel technologies for stem cell preservation, processing, and storage, an increase in hematopoietic stem cell transplantation (HSCT) procedures, and increased investments in stem cell-based research. High operational expenses associated with stem cell banking, as well as strict regulatory frameworks, are projected to limit market expansion to some extent.

The stem cell banking market is divided into placental, embryonic, bone marrow, adipose tissue, dental pulp, and other stem cell sources, depending on the source. The placental stem cells category is predicted to account for the greatest proportion of the stem cell banking market in 2018, with 73.9 percent. The enormous increase in the number of placental and cord banks across key markets (particularly the US and Europe) along with increased public awareness about the therapeutic potential of stem cell sources is largely responsible for this segment's large share.

The stem cell banking industry can be divided into three categories based on application: clinical applications, research applications, and personalised banking applications. In 2018, the personalised banking applications category is predicted to account for the greatest proportion of the stem cell banking market and develop at the quickest CAGR. This is due to service providers' premium pricing of service plans and the special benefits of customised banking over communal and public banking (such as exclusive member rights for stored stem cells and efficient quality analysis, sample testing, and sample processing).

In 2018, North America is predicted to hold the highest proportion of the worldwide stem cell banking market, with Asia Pacific coming in second. Factors such as an expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (particularly for hematopoietic and autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments in stem cell research are propelling the stem cell burgeoning.

Growing public awareness of stem cells' therapeutic potential; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increased stem cell-based research are all driving market expansion. On the other hand, market growth is likely to be constrained by high operational expenses associated with stem cell banking and strict regulatory frameworks. The majority of market stakeholders in the stem cell banking business confront key hurdles such as low acceptance of stem cell banking services in poorer countries and socio-ethical concerns about embryonic stem cells (ESCs).

With the increased availability of clinical evidence, public awareness of stem cells' medicinal potential is growing around the world. Furthermore, stem cells have been shown to treat more than 80 diseases and disorders, including hematopoiesis, immunodeficiency diseases, metabolic disorders, cancer, and degenerative neuromuscular disorders. With rising per capita disposable income in developing countries and predicted lower product costs associated with stem cell therapies, public awareness and adoption of stem cell therapies, as well as stem cell banking services, are expected to increase during the research period.

During the sample processing, quality testing, and sample preservation and storage operations, cell banks, tissue banks, and biobanks spend a lot of money. This does not include the cost of buying and maintaining high-end instruments, reagents, and consumables. As a result, service providers' operational costs are considerable. Furthermore, increased regulatory requirements for stem cell preservation and banking, as well as the costly licensing/approval procedure for the formation of stem cell banks in industrialised countries, are projected to add to stem cell banking service providers' overall operational expenses.

Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), and ViaCord (US) dominated the global stem cell banking market in 2017. (US). Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico) were among the other major competitors in the stem cell banking sector.

In 2017, Cord Blood Registry (CBR) Systems was the market leader in the global stem cell banking market. In the United States, the corporation has a significant consumer base and a widespread presence. The company primarily focuses on using inorganic growth techniques including collaborations and partnerships to advance its umbilical cord preservation services. In this line, the business teamed up with the New York Stem Cell Foundation in the United States in 2017 to create induced pluripotent stem cells from umbilical cords. In addition, in 2015, the company formed a strategic partnership with Global Cord Blood Corporation (China) to integrate its collecting, processing, and storage processes.

In 2017, Cordlife was ranked second in the global stem cell banking market. With a strong presence in eight countries and high-quality services, the company is a market leader in Asian stem cell banking. To maintain its dominance in Asia, the corporation relies primarily on expanding its customer base through agreements. In 2017, for example, the company collaborated with IPS Trading and Service Joint Stock Company (Vietnam) to provide umbilical cord banking and non-invasive metabolic newborn screening in Vietnam. Similarly, the company partnered with Bio Secure Company Limited (Myanmar) in 2016 to provide umbilical cord banking services.

In 2017, Cryo-Cell International ranked third in the stem cell banking market. In the global market, the firm is one of the most important private stem cell banking suppliers. The company's primary strengths are its large geographic presence and its unique state-of-the-art banking technology. The company's major focus is on securing patents for umbilical cord blood and tissue collection, testing, processing, and preservation. In 2015, for example, the company purchased assets from Prepacyte-CB (a cord blood business of CytoMedical Design Group LLC) in order to develop its existing technology for cord blood and tissue processing.

Life Cell International (India) modified and improved its umbilical cord collection kit in 2017.

To expand its position in the German stem cell banking sector, Vita34 AG (Germany) bought Seracell Pharma AG (Germany) in 2017.

The Foundation for the Accreditation of Cellular Therapy (FACT) granted StemCyte India Therapeutics Pvt. Ltd. (India), a subsidiary of StemCyte (US), accreditation for both public and private stem cell banking services in 2016.

Cord Blood Registry (CBR) Systems (US) and the New York Stem Cell Foundation (US) collaborated in 2015 to create induced pluripotent stem cells from umbilical cords.

Comments

Post a Comment

Popular posts from this blog

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

-
Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...
Read more

10 Benefits Of Paper And Packaging Market That May Change Your Perspective.

-
Image
The paper packaging market during the projection period of 2021-2026, the paper packaging market grew at a CAGR of 3.87 percent. The COVID-19 epidemic wreaked havoc on the packaging sector, with the impacts of nationwide lockdown, corporations shifting their sourcing away from China, and materials used in packaging being reconsidered. Although there has been a substantial impact on the supply side of paper packaging, a large growth in end-user demand in specific applications has significantly expanded the scope of paper packaging. Paper packaging is a flexible and cost-effective way to protect, store, and transport a variety of items. It can also be tailored to match the needs of certain customers or products. The characteristics of paper packaging, such as lightweight, biodegradability, and recyclability, make it a crucial component for packaging. The market for paper packaging is being driven by rising consumer awareness of sustainable packaging and tight rules enforced by various en...
Read more

5 Various Ways To Do Obesity Management Drugs Market.

-
Image
Obesity is a medical disorder in which the body accumulates too much fat. Excessive food intake, hereditary vulnerability, and a lack of physical activity are all frequent causes of the Obesity Management Drugs Market . Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, and Liraglutide are some of the drugs used to treat obesity. Over the forecast period, the worldwide Obesity Management Drugs Market is expected to rise due to the high prevalence of obesity. According to MedAlertHelp.org, nearly 1.9 billion adults globally are considered overweight. Furthermore, obesity R&D is expected to contribute to the global obesity management drugs market's growth. According to a short study to be presented at e-ECE 2020, the 22nd European Congress of Endocrinology, the probiotic strain Bifidobacterium breve, when combined with a calorie-controlled diet, may aid in the weight loss of obese children and adolescents. The global obesity treatment pharmaceuticals ma...
Read more